Aida Tomomi, Imahashi Risa, Tanaka Kohichi
Laboratory of Molecular Neuroscience, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-Ku, Tokyo, 113-8510, Japan.
Dev Growth Differ. 2014 Jan;56(1):34-45. doi: 10.1111/dgd.12101. Epub 2013 Nov 25.
Gene-targeted mutant animals, such as knockout or knockin mice, have dramatically improved our understanding of the functions of genes in vivo and the genetic diversity that characterizes health and disease. However, the generation of targeted mice relies on gene targeting in embryonic stem (ES) cells, which is a time-consuming, laborious, and expensive process. The recent groundbreaking development of several genome editing technologies has enabled the targeted alteration of almost any sequence in any cell or organism. These technologies have now been applied to mouse zygotes (in vivo genome editing), thereby providing new avenues for simple, convenient, and ultra-rapid production of knockout or knockin mice without the need for ES cells. Here, we review recent achievements in the production of gene-targeted mice by in vivo genome editing.
基因靶向突变动物,如基因敲除或基因敲入小鼠,极大地增进了我们对基因在体内功能以及构成健康和疾病特征的遗传多样性的理解。然而,靶向小鼠的产生依赖于胚胎干细胞(ES细胞)中的基因靶向技术,这是一个耗时、费力且昂贵的过程。最近几种基因组编辑技术的突破性发展使得几乎可以在任何细胞或生物体中对任何序列进行靶向改变。这些技术现已应用于小鼠受精卵(体内基因组编辑),从而为无需ES细胞即可简单、便捷且超快速地生产基因敲除或基因敲入小鼠提供了新途径。在此,我们综述了通过体内基因组编辑生产基因靶向小鼠的最新成果。